Uncategorized

AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak

Published

on

AstraZeneca will push through with its other Phase 3 studies for volrustomig, including in cervical cancer and mesothelioma.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version